(Q35034575)

5 August 2017

Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial (English)

1 reference

5 August 2017

P-L Jerevall

1

1 reference

5 August 2017

X-J Ma

2

1 reference

5 August 2017

H Li

3

1 reference

5 August 2017

R Salunga

4

1 reference

5 August 2017

N C Kesty

5

1 reference

5 August 2017

M G Erlander

6

1 reference

5 August 2017

D C Sgroi

7

1 reference

5 August 2017

B Holmlund

8

1 reference

5 August 2017

L Skoog

9

1 reference

5 August 2017

T Fornander

10

1 reference

5 August 2017

B Nordenskjöld

11

1 reference

5 August 2017

O Stål

12

1 reference

5 August 2017

language of work or name

English

0 references

publication date

10 May 2011

1 reference

British Journal of Cancer

5 August 2017

1 reference

5 August 2017

104

1 reference

5 August 2017

11

1 reference

5 August 2017

1762-1769

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2011.145

5 August 2017

0 references

cites work

Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

Enabling personalized cancer medicine through analysis of gene-expression patterns

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

Proliferation: the most prominent predictor of clinical outcome in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

Concordance among gene-expression-based predictors for breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

A gene-expression signature as a predictor of survival in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

Cytosol estradiol receptor in human mammary carcinoma: An assay based on isoelectric focusing in polyacrylamide gel

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111159

First--select the target: better choice of adjuvant treatments for breast cancer patients.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.145

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.145

The Nottingham prognostic index in primary breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21559019

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21559019

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21559019

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2011.145

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference